These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Blood transfusion induced changes in cell-mediated lympholysis: to immunize or not to immunize. Lagaaij EL; Ruigrok MB; van Rood JJ; Hendriks GF; van der Woude F; Weimar W; van Houwelingen HC; Goulmy E J Immunol; 1991 Nov; 147(10):3348-52. PubMed ID: 1940340 [TBL] [Abstract][Full Text] [Related]
4. Development of specific nonreactivity in human cadaveric renal allograft recipients. Sengar DP; Rashid A; Harris JE Tissue Antigens; 1976 May; 7(5):281-90. PubMed ID: 132717 [TBL] [Abstract][Full Text] [Related]
5. Evidence of donor-specific cellular suppressor activity in donor-specific cell-mediated lympholysis unresponsiveness in renal transplant patients. Wramner L; Olausson M; Söderström T; Lindholm L; Rydberg L; Brynger H Transplantation; 1987 Sep; 44(3):390-5. PubMed ID: 2957836 [TBL] [Abstract][Full Text] [Related]
6. HLA-DR matched transfusions: development of donor-specific T- and B-cell antibodies and renal allograft outcome. Christiaans MH; van Hooff JP; Nieman F; van den Berg-Loonen EM Transplantation; 1999 Apr; 67(7):1029-35. PubMed ID: 10221489 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of pretransplant donor anti-recipient cytotoxic and helper T lymphocyte responses as correlates of acute graft-vs.-host disease and survival after unrelated marrow transplantation. Pei J; Martin PJ; Longton G; Masewicz S; Mickelson E; Petersdorf E; Anasetti C; Hansen J Biol Blood Marrow Transplant; 1997 Aug; 3(3):142-9. PubMed ID: 9310191 [TBL] [Abstract][Full Text] [Related]
8. Comparison of cell-mediated lympholysis and mixed lymphocyte culture in the immunologic evaluation for renal transplantation. Harmon WE; Parkman R; Lavin PT; Grupe WE; Ingelfinger JR; Yunis EJ; Levey RH J Immunol; 1982 Oct; 129(4):1573-7. PubMed ID: 6213715 [TBL] [Abstract][Full Text] [Related]
9. Donor-specific decreased cell-mediated cytotoxicity in recipients of well functioning, one HLA haplotype-mismatched kidney allografts. Pfeffer PF; Thorsby E; Hirschberg H Transplantation; 1983 Feb; 35(2):156-60. PubMed ID: 6187111 [TBL] [Abstract][Full Text] [Related]
10. Occurrence of posttransplant donor-specific cell-mediated lympholysis nonreactivity in renal allograft recipients with perioperative transfusions only. Goulmy E; Blokland E; Fassbinder W; Persijn G; van Rood JJ Transplantation; 1985 Jan; 39(1):105-7. PubMed ID: 2578234 [No Abstract] [Full Text] [Related]
11. MLC compatibility, HLA-D and DR typing in cadaver kidney transplantations. Thomsen M; Morling N; Ladefoged J; Løkkegård H; Jakobsen B; Svejgaard A; Thaysen JH Scand J Urol Nephrol Suppl; 1980; 54():32-5. PubMed ID: 6452681 [TBL] [Abstract][Full Text] [Related]
12. Pretransplant monitoring of donor-recipient compatibility. Thomas F; Thomas J; Mendez G; Kirchoff C; Lee HM Transplantation; 1977 Dec; 24(6):442-8. PubMed ID: 145674 [TBL] [Abstract][Full Text] [Related]
13. The relationship between donor-recipient lymphocytotoxicity and the transfusion response using HLA-matched platelet concentrates. Herzig RH; Terasaki PI; Trapani RJ; Herzig GP; Graw RG Transfusion; 1977; 17(6):657-61. PubMed ID: 595123 [TBL] [Abstract][Full Text] [Related]
14. The new serology of histocompatibility testing and its significance in human renal transplantation. Braun WE Urol Clin North Am; 1976 Oct; 3(3):503-25. PubMed ID: 136083 [No Abstract] [Full Text] [Related]